secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2026-02-18T23:59:59+00:00
Accession:  0001193125-26-056983
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma sets 2026 annual meeting for April 13; shareholder deadlines on Feb 28.
--------------------------------------------------------------------------------

- Annual meeting date: April 13, 2026.
- Shareholder proposals under Rule 14a-8 must be received by February 28, 2026.
- Director nominations and other business also due by February 28, 2026 per Bylaws and Rule 14a-19.
- Proxies may exercise discretionary voting on late proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000119312526056983/0001193125-26-056983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000119312526056983/cue-20260218.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-056983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer